Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study
Crossref DOI link: https://doi.org/10.1186/s13075-016-0932-2
Published Online: 2016-01-28
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yamanaka, Hisashi
Tanaka, Yoshiya
Takeuchi, Tsutomu
Sugiyama, Naonobu
Yuasa, Hirotoshi
Toyoizumi, Shigeyuki
Morishima, Yosuke
Hirose, Tomohiro
Zwillich, Samuel
Funding for this research was provided by:
Pfizer (US)